Huons Global Co., Ltd. (KOSDAQ:084110)

Market Cap	770.01B +56.1%
Revenue (ttm)	847.45B +4.2%
Net Income	28.84B +11.8%
EPS	2,360.00 +11.7%
Shares Out	12.20M
PE Ratio	26.74
Forward PE	n/a
Dividend	880.00 (1.34%)
Ex-Dividend Date	Apr 2, 2026

Volume	47,395
Average Volume	68,088
Open	65,900
Previous Close	65,700
Day's Range	62,600 - 66,600
52-Week Range	40,800 - 76,700
Beta	0.96
RSI	52.77
Earnings Date	May 14, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 118
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084110

Financial Performance

In 2025, Huons Global's revenue was 847.45 billion, an increase of 4.18% compared to the previous year's 813.46 billion. Earnings were 28.84 billion, an increase of 11.82%.